glp 1 agonistleri Schematic illustration of monoagonists, dual agonists and triple Current Perspectives on GLP-1 Agonists

Las grandes empresas farmacuticas luchan por el mercado de la prdida de peso de u$s150.000 millones El mercado global de medicamentos para la obesidad est experimentando una carrera frentica entre las grandes farmacuticas y startups biotecnolgicas para capturar una parte de lo que se proyecta ser un negocio de hasta u$s150.000 millones anuales en la prxima dcada

Description Overview BPC157 is a synthetic pentadecapeptide (15 amino acids) that comes from a fragment of a larger endogenous gastric protein complex commonly referred to as Body Protection Compound (BPC)

here are key points from this work: Relationship Both coaches and patients with obesity in this study agree a key element for effective treatment is a collaborative alliance built on trust, openness, listening, and self-awareness

Long COVID from rheumatology perspective - a narrative review